Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1951 1
1952 3
1956 1
1957 1
1961 1
1962 1
1975 1
1979 1
1980 1
1994 2
1995 1
1996 3
1997 5
1998 1
1999 3
2001 2
2002 5
2003 2
2004 7
2005 4
2006 4
2007 10
2008 10
2009 5
2010 12
2011 12
2012 12
2013 18
2014 10
2015 17
2016 12
2017 14
2018 16
2019 16
2020 16
2021 20
2022 13
2023 7
2024 12
2025 18

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

259 results

Results by year

Filters applied: . Clear all
Page 1
Neoadjuvant relatlimab and nivolumab in resectable melanoma.
Amaria RN, Postow M, Burton EM, Tetzlaff MT, Ross MI, Torres-Cabala C, Glitza IC, Duan F, Milton DR, Busam K, Simpson L, McQuade JL, Wong MK, Gershenwald JE, Lee JE, Goepfert RP, Keung EZ, Fisher SB, Betof-Warner A, Shoushtari AN, Callahan M, Coit D, Bartlett EK, Bello D, Momtaz P, Nicholas C, Gu A, Zhang X, Korivi BR, Patnana M, Patel SP, Diab A, Lucci A, Prieto VG, Davies MA, Allison JP, Sharma P, Wargo JA, Ariyan C, Tawbi HA. Amaria RN, et al. Among authors: bello d. Nature. 2022 Nov;611(7934):155-160. doi: 10.1038/s41586-022-05368-8. Epub 2022 Oct 26. Nature. 2022. PMID: 36289334 Free PMC article. Clinical Trial.
Adjuvant immunotherapy for melanoma.
Thomas D, Bello DM. Thomas D, et al. Among authors: bello dm. J Surg Oncol. 2021 Mar;123(3):789-797. doi: 10.1002/jso.26329. J Surg Oncol. 2021. PMID: 33595889 Review.
Assessment and Mitigation of Exposure of 3-D Printer Emissions.
Kim B, Shin JH, Kim HP, Jo MS, Kim HS, Lee JS, Lee HK, Kwon HC, Han SG, Kang N, Gulumian M, Bello D, Yu IJ. Kim B, et al. Among authors: bello d. Front Toxicol. 2022 Feb 18;3:817454. doi: 10.3389/ftox.2021.817454. eCollection 2021. Front Toxicol. 2022. PMID: 35295129 Free PMC article.
Biomarkers in long COVID-19: A systematic review.
Lai YJ, Liu SH, Manachevakul S, Lee TA, Kuo CT, Bello D. Lai YJ, et al. Among authors: bello d. Front Med (Lausanne). 2023 Jan 20;10:1085988. doi: 10.3389/fmed.2023.1085988. eCollection 2023. Front Med (Lausanne). 2023. PMID: 36744129 Free PMC article.
Broad-spectrum synthetic carbohydrate receptors (SCRs) inhibit viral entry across multiple virus families.
Ezzatpour S, Thakur K, Erzoah Ndede K, Buchholz DW, Choi A, Imbiakha B, Carter J, Onofrei D, Eaton B, Postnikova E, Murphy M, Tapia BC, Bello D, Pasari S, Russo A, Babayev M, Holland GP, Holbrook MR, Caddy SL, Moran SJ, Davachi SM, Monreal IA, Sahler J, Ortega V, Miranda JM, Whittaker GR, Jager MC, Bhagwat SK, Chopra P, Jan-Boons G, Marianski M, Braunschweig AB, Aguilar HC. Ezzatpour S, et al. Among authors: bello d. Sci Adv. 2025 Aug 29;11(35):eady3554. doi: 10.1126/sciadv.ady3554. Epub 2025 Aug 27. Sci Adv. 2025. PMID: 40864723 Free PMC article.
The GIST of targeted therapy for malignant melanoma.
Bello DM, Dematteo RP, Ariyan CE. Bello DM, et al. Ann Surg Oncol. 2014 Jun;21(6):2059-67. doi: 10.1245/s10434-013-3373-z. Epub 2014 Feb 15. Ann Surg Oncol. 2014. PMID: 24531699 Free PMC article. Review.
259 results